A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study
dc.contributor.author | Wranke, A. | |
dc.contributor.author | Yurdaydin, C. | |
dc.contributor.author | Heidrich, B. | |
dc.contributor.author | Kalliopi, Z. | |
dc.contributor.author | Yalcin, K. | |
dc.contributor.author | Fehmi, T. | |
dc.contributor.author | Akarca, U. | |
dc.date.accessioned | 2024-04-24T16:18:49Z | |
dc.date.available | 2024-04-24T16:18:49Z | |
dc.date.issued | 2018 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCE | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.identifier.doi | 10.1016/S0168-8278(18)31261-3 | |
dc.identifier.endpage | S507 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.startpage | S507 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(18)31261-3 | |
dc.identifier.uri | https://hdl.handle.net/11468/16297 | |
dc.identifier.volume | 68 | en_US |
dc.identifier.wos | WOS:000461068602228 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal of Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study | en_US |
dc.title | A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study | |
dc.type | Conference Object | en_US |